Page last updated: 2024-10-30

lansoprazole and Scleroderma, Systemic

lansoprazole has been researched along with Scleroderma, Systemic in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abignano, G1
Scott, N1
Wollheim, FA1
Emery, P1
Buch, MH1
Del Galdo, F1
Chatterjee, S1

Other Studies

2 other studies available for lansoprazole and Scleroderma, Systemic

ArticleYear
Collagenous colitis in systemic sclerosis: an overlooked and treatable complication.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:5

    Topics: Aged; Biopsy, Needle; Budesonide; Colitis, Collagenous; Colonoscopy; Drug Administration Schedule; F

2014
Watermelon stomach.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Jul-15, Volume: 179, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Follow-Up Studies; Gastric Antral Vascular Ectasia; G

2008